Back to Research PerspectivesThe RE-Movement Science Series
RE-COVERY

UNDERSTANDING MUSCLE, TENDON & TISSUE RECOVERY

RE-COVERY is an educational resource about the biology of tissue repair and the current research on peptides such as BPC-157, TB-500 (thymosin beta-4) and GHK-Cu.

SCIENCE

INFORMS

HEALTHIER

TOMORROWS

KNOWLEDGE

SUPPORTS

INFORMED

CONVERSATIONS

RECOVERY TODAY. A STRONGER TOMORROW.

HOW SOFT TISSUE HEALS

Tissue repair is a complex, multi-phase process that occurs in overlapping stages.

1

INFLAMMATION

The body responds to injury with inflammation, which helps remove debris and initiate healing.

2

REPAIR & PROLIFERATION

Cells such as fibroblasts produce new tissue, blood vessels form (angiogenesis), and collagen begins to build.

3

REMODELING

Tissue strengthens and reorganizes over time, improving function, flexibility and resilience.

MuscleContracts and generates force
TendonConnects muscle to bone
LigamentStabilizes joints
BoneProvides structure and support

WHY TISSUE HEALTH MATTERS

Supports mobility and function
Helps maintain joint stability
Contributes to physical performance
Important for long-term musculoskeletal health

BPC-157

A PEPTIDE UNDER INVESTIGATION
  • BPC-157 is a synthetic peptide derived from a protein found in the stomach.
  • It has been studied primarily in preclinical (animal) models for its potential effects on tendon, ligament, muscle, and gastrointestinal healing.
  • Human clinical evidence is very limited, and there is no established clinical efficacy for musculoskeletal injury or repair in humans.
Status: PreclinicalPubMed Review

TB-500

THYMOSIN BETA-4–RELATED RESEARCH
  • TB-500 is a synthetic version of a fragment of thymosin beta-4, a naturally occurring peptide involved in cell movement (migration) and tissue repair.
  • Preclinical research has examined its potential role in angiogenesis, inflammation modulation, and tissue regeneration.
  • Human evidence for TB-500 in orthopedic or musculoskeletal conditions is currently lacking.
FDA Category 2 ConcernFDA Safety Notice

GHK-Cu

A COPPER-BINDING PEPTIDE
  • GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a naturally occurring peptide that binds copper ions.
  • It has been studied for its role in tissue remodeling, wound repair, collagen production, and anti-inflammatory processes.
  • Most human research has focused on skin and wound healing. Evidence for injectable use in musculoskeletal recovery is limited.
Route-Specific Safety NoteFDA Notice

WHAT THE EVIDENCE SHOWS

Preclinical studies suggest potential benefits for tissue healing, inflammation modulation, and cell migration.

Most of the existing research is from animal or laboratory studies.

High-quality human clinical trials are limited, so safety and effectiveness in humans have not been established.

Promising research does not mean a treatment is approved, proven effective, or appropriate for every patient.

REGULATORY & SAFETY CONSIDERATIONS

BPC-157, TB-500 (thymosin beta-4 related substances), and injectable GHK-Cu are not FDA-approved treatments for muscle, tendon, or tissue repair.

Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.

The FDA has identified BPC-157, TB-500–related substances, and injectable GHK-Cu as bulk drug substances that may present significant safety risks due to limited human safety data.

QUESTIONS TO DISCUSS WITH A HEALTHCARE PROFESSIONAL

  • What is the current evidence for these peptides in humans?
  • Are any of these substances FDA-approved for my condition?
  • What are the known and unknown risks?
  • Are there alternative, evidence-based treatment options?
  • How would my progress be monitored?
  • What role do rehabilitation, physical therapy, and other non-drug approaches play?
  • Is a compounded medication being considered, and why?

ESTABLISHED MUSCULOSKELETAL RECOVERY APPROACHES

Evaluation of a muscle, tendon, or connective-tissue injury involves determining the location, severity, and cause of the injury. Depending upon the condition, established clinical approaches to recovery include:

Activity ModificationProtecting injured tissue from overload
Physical TherapyTargeted rehabilitation and loading protocols
Strength & MobilityProgressive functional restoration
Nutritional SupportAdequate protein and micronutrient status

LEARN MORE

Reliable, up-to-date information is available from:
U.S. Food & Drug Administration (FDA)

Information on bulk drug substances, safety risks, and compounding policies.

https://www.fda.gov/drugs
PubMed — National Library of Medicine

Search for peer-reviewed scientific studies, clinical trials, and reviews.

https://pubmed.ncbi.nlm.nih.gov
National Institutes of Health (NIH)

Research on wound healing, connective tissue repair, and regenerative biology.

https://www.nih.gov
Educational Disclaimer

This page is provided for general educational purposes only. It is not intended to provide medical advice, diagnosis, or treatment. References to peptides, biological mechanisms, laboratory research, animal studies, or areas of clinical investigation are provided for educational purposes and should not be interpreted as a recommendation or endorsement of a particular substance or treatment.

Discussion of an investigational substance does not establish that the substance is safe, effective, FDA-approved, or appropriate for medical use. Treatment decisions should be individualized and made with an appropriately licensed healthcare professional based on medical history, diagnosis, current health, medications, potential risks, available clinical evidence, and professional medical judgment. FDA approval status, compounding policies, clinical evidence, and regulatory requirements may change. Current information should be verified through the U.S. Food & Drug Administration and other recognized medical resources.

RE-MovementEDUCATION TODAY. HEALTHIER TOMORROWS.
Back to Research Perspective Library
Back to Research Perspectives